Ascletis Pharma (HKSE:01672) Marketable Securities : HK$2,153.96 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Ascletis Pharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ascletis Pharma's Marketable Securities for the quarter that ended in Dec. 2023 was HK$2,153.96 Mil.

Ascletis Pharma's annual Marketable Securities increased from Dec. 2021 (HK$6.37 Mil) to Dec. 2022 (HK$2,320.83 Mil) but then declined from Dec. 2022 (HK$2,320.83 Mil) to Dec. 2023 (HK$2,153.96 Mil).

Ascletis Pharma Marketable Securities Historical Data

The historical data trend for Ascletis Pharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascletis Pharma Marketable Securities Chart

Ascletis Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

6.37

2,320.83

2,153.96

Ascletis Pharma Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial										6.37	6.10	2,320.83	2,238.65	2,153.96

Ascletis Pharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Ascletis Pharma (HKSE:01672) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ascletis Pharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ascletis Pharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascletis Pharma (HKSE:01672) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascletis Pharma Inc (HKSE:01672) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

ASCLF:USA

Address

198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200

Website

https://www.ascletis.com

Ascletis Pharma Inc is an investment holding company engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. ritonavir tablets, GANOVO, and ASCLEVIR. Geographically, it operates in Mainland China and other countries.

Ascletis Pharma (HKSE:01672) Headlines

No Headlines